Ahammune Biosciences Secures $5M for Vitiligo Trials
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
- Latest
- Trending
Ahammune Biosciences raises $5M led by pi Ventures for Phase II trials, expanding R&D for skin disease treatments.
Discover how VR software is set to grow at 41.99% CAGR by 2030, driven by innovations in hardware and applications.
AI empowers both scammers and defenders in data security, affecting banking, health, and more. Learn ways to safeguard your info.
Zydus and Perfect Day join forces to create eco-friendly proteins, revolutionizing sustainable food production worldwide.
Explore how AI agents like Workday Illuminate and Salesforce redefine business with intelligent automation and innovation.
Explore the latest market signals and social media trends affecting trading decisions and investment strategies.
Explore the latest market signals influenced by social media trends and insider rumors.
Get the latest XRP price analysis and projections for the next 48 hours, week, and month based on data and ...
Ethereum sees a 14.5% price surge, buoyed by 5 million active addresses and increased buyer activity.
Everyday People Financial secures C$6M debt financing for CCS acquisition, enhancing revenue cycle management in strategic move.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.